HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2006-0256v1 25/1/107    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Vanheusden, K. Articles by Vandekerckhove, B. Search for Related Content PubMed PubMed Citation Articles by Vanheusden, K. Articles by Vandekerckhove, B.

TISSUE-SPECIFIC STEM CELLS

In Vitro Expanded Cells Contributing to Rapid Severe Combined Immunodeficient Repopulation Activity Are CD34⁺38^–33⁺90⁺45RA^–

^aDepartment of Clinical Chemistry, Microbiology and Immunology, Faculty of Medicine and Health Sciences, Ghent University, Ghent University Hospital, Ghent, Belgium;
^bDienst voor het Bloed, Rode Kruis-Vlaanderen, Ghent, Belgium

Key Words. Hematopoiesis • Stem cell • Stem cell culture • Nonobese diabetic/severe combined immunodeficient mice

Correspondence: Bart Vandekerckhove, M.D., Ph.D., Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, 4 Blok A, De Pintelaan 185, B-9000 Ghent, Belgium. Telephone: 32(0)9-240-60-65; Fax: 32(0)9-240-36-59; e-mail: Bart.Vandekerckhove{at}Ugent.be

Received April 25, 2006; accepted for publication September 1, 2006.
First published online in STEM CELLS EXPRESS   September 14, 2006.



Expansion of hematopoietic stem cells could be used clinically to shorten the prolonged aplastic phase after umbilical cord blood (UCB) transplantation. In this report, we investigated rapid severe combined immunodeficient (SCID) repopulating activity (rSRA) 2 weeks after transplantation of CD34⁺ UCB cells cultured with serum on MS5 stromal cells and in serum- and stroma-free cultures. Various subpopulations obtained after culture were studied for rSRA. CD34⁺ expansion cultures resulted in vast expansion of CD45⁺ and CD34⁺ cells. Independent of the culture method, only the CD34⁺33⁺38^– fraction of the cultured cells contained rSRA. Subsequently, we subfractionated the CD34⁺38^– fraction using stem cell markers CD45RA and CD90. In vitro differentiation cultures showed CD34⁺ expansion in both CD45RA^– and CD90⁺ cultures, whereas little increase in CD34⁺ cells was observed in both CD45RA⁺ and CD90^– cultures. By four-color flow cytometry, we could demonstrate that CD34⁺38^–45RA^– and CD34⁺38^–90⁺ cell populations were largely overlapping. Both populations were able to reconstitute SCID/nonobese diabetic mice at 2 weeks, indicating that these cells contained rSRA activity. In contrast, CD34⁺38^–45RA⁺ or CD34⁺38^–90^– cells contributed only marginally to rSRA. Similar results were obtained when cells were injected intrafemorally, suggesting that the lack of reconstitution was not due to homing defects. In conclusion, we show that after in vitro expansion, rSRA is mediated by CD34⁺38^–90⁺45RA^– cells. All other cell fractions have limited reconstitutive potential, mainly because the cells have lost stem cell activity rather than because of homing defects. These findings can be used clinically to assess the rSRA of cultured stem cells.